Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — January 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Jan 8, 2026
Purchase
Shares
294,117
Price
$17.00
Total Value
$5.00M
Shares Held After
2,908,332
% of Holdings
10.1%
Jan 8, 2026
Purchase
Shares
117,647
Price
$17.00
Total Value
$2.00M
Shares Held After
5,702,536
% of Holdings
2.1%
Jan 8, 2026
Sale
Shares
300
Price
$75.20
Total Value
$22.56K
Shares Held After
4,538,447
% of Holdings
0.0%
Jan 8, 2026
Sale
Shares
8,135
Price
$74.38
Total Value
$605.06K
Shares Held After
4,538,747
% of Holdings
0.2%
Jan 8, 2026
Sale
Shares
11,565
Price
$73.65
Total Value
$851.81K
Shares Held After
4,546,882
% of Holdings
0.3%
Jan 8, 2026
Sale
Shares
400
Price
$75.16
Total Value
$30.06K
Shares Held After
735,686
% of Holdings
0.1%
Jan 8, 2026
Sale
Shares
8,085
Price
$74.38
Total Value
$601.34K
Shares Held After
736,086
% of Holdings
1.1%
Jan 8, 2026
Sale
Shares
11,515
Price
$73.64
Total Value
$848.02K
Shares Held After
744,171
% of Holdings
1.5%

Acumen Pharmaceuticals, Inc. (ABOS)

Zuga Matt — CFO & Chief Business Officer
Jan 8, 2026
Sale
Shares
6,888
Price
$1.82
Total Value
$12.51K
Shares Held After
209,951
% of Holdings
3.2%

Acumen Pharmaceuticals, Inc. (ABOS)

Barton Russell — Chief Operating Officer
Jan 8, 2026
Sale
Shares
3,530
Price
$1.86
Total Value
$6.56K
Shares Held After
123,269
% of Holdings
2.8%

Acumen Pharmaceuticals, Inc. (ABOS)

Meisner Derek M — Chief Legal Officer & Corp Sec
Jan 8, 2026
Sale
Shares
30,092
Price
$1.82
Total Value
$54.87K
Shares Held After
97,548
% of Holdings
23.6%

Acumen Pharmaceuticals, Inc. (ABOS)

Meisner Derek M — Chief Legal Officer & Corp Sec
Jan 8, 2026
Sale
Shares
6,819
Price
$1.82
Total Value
$12.38K
Shares Held After
127,640
% of Holdings
5.1%
Jan 8, 2026
Sale
Shares
8,143
Price
$1.82
Total Value
$14.82K
Shares Held After
611,839
% of Holdings
1.3%

SI-BONE, Inc. (SIBN)

DUNN JEFFREY W — Director
Jan 8, 2026
Sale
Shares
20,000
Price
$21.28
Total Value
$425.51K
Shares Held After
80,115
% of Holdings
20.0%
Jan 8, 2026
Sale
Shares
3,593
Price
$7.26
Total Value
$26.09K
Shares Held After
35,720
% of Holdings
9.1%

GLOBUS MEDICAL INC (GMED)

Kline Kyle — Senior Vice President, CFO
Jan 8, 2026
Sale
Shares
3,594
Price
$101.10
Total Value
$363.35K
Shares Held After
0
% of Holdings
100.0%
Jan 8, 2026
Sale
Shares
2,000
Price
$101.10
Total Value
$202.20K
Shares Held After
10,419
% of Holdings
16.1%

PTC THERAPEUTICS, INC. (PTCT)

Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Jan 8, 2026
Sale
Shares
1,034
Price
$76.45
Total Value
$79.05K
Shares Held After
72,693
% of Holdings
1.4%

PTC THERAPEUTICS, INC. (PTCT)

Pauwels Eric — CHIEF BUSINESS OFFICER
Jan 8, 2026
Sale
Shares
1,454
Price
$76.45
Total Value
$111.16K
Shares Held After
82,887
% of Holdings
1.7%

PTC THERAPEUTICS, INC. (PTCT)

Pauwels Eric — CHIEF BUSINESS OFFICER
Jan 8, 2026
Sale
Shares
587
Price
$76.98
Total Value
$45.19K
Shares Held After
84,341
% of Holdings
0.7%

PTC THERAPEUTICS, INC. (PTCT)

Pauwels Eric — CHIEF BUSINESS OFFICER
Jan 8, 2026
Sale
Shares
2,561
Price
$76.42
Total Value
$195.71K
Shares Held After
84,928
% of Holdings
2.9%
Jan 8, 2026
Sale
Shares
2,514
Price
$76.45
Total Value
$192.20K
Shares Held After
394,453
% of Holdings
0.6%

PTC THERAPEUTICS, INC. (PTCT)

Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Jan 8, 2026
Sale
Shares
866
Price
$76.45
Total Value
$66.21K
Shares Held After
92,428
% of Holdings
0.9%
Jan 8, 2026
Sale
Shares
1,286
Price
$76.45
Total Value
$98.31K
Shares Held After
113,626
% of Holdings
1.1%
Jan 8, 2026
Sale
Shares
265
Price
$77.07
Total Value
$20.42K
Shares Held After
114,912
% of Holdings
0.2%
Jan 8, 2026
Sale
Shares
2,482
Price
$76.56
Total Value
$190.02K
Shares Held After
115,177
% of Holdings
2.1%

PTC THERAPEUTICS, INC. (PTCT)

Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Jan 8, 2026
Sale
Shares
59
Price
$76.45
Total Value
$4.51K
Shares Held After
6,791
% of Holdings
0.9%

PTC THERAPEUTICS, INC. (PTCT)

Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Jan 8, 2026
Sale
Shares
881
Price
$76.45
Total Value
$67.35K
Shares Held After
115,196
% of Holdings
0.8%

Enliven Therapeutics, Inc. (ELVN)

Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Jan 8, 2026
Sale
Shares
33,802
Price
$24.92
Total Value
$842.47K
Shares Held After
856,386
% of Holdings
3.8%

Enliven Therapeutics, Inc. (ELVN)

Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Jan 8, 2026
Sale
Shares
7,500
Price
$20.13
Total Value
$150.96K
Shares Held After
890,188
% of Holdings
0.8%
Jan 8, 2026
Sale
Shares
8,015
Price
$25.04
Total Value
$200.66K
Shares Held After
29,392
% of Holdings
21.4%
Jan 8, 2026
Sale
Shares
1,620
Price
$25.00
Total Value
$40.50K
Shares Held After
25,545
% of Holdings
6.0%
Jan 8, 2026
Sale
Shares
7,716
Price
$0.63
Total Value
$4.86K
Shares Held After
2,393,527
% of Holdings
0.3%

Phreesia, Inc. (PHR)

VanDuyn Amy Beth — SVP, Human Resources
Jan 8, 2026
Sale
Shares
2,602
Price
$17.01
Total Value
$44.25K
Shares Held After
160,238
% of Holdings
1.6%

Phreesia, Inc. (PHR)

Roberts Evan — President, Provider Solutions
Jan 8, 2026
Sale
Shares
6,317
Price
$17.01
Total Value
$107.43K
Shares Held After
834,632
% of Holdings
0.8%

Phreesia, Inc. (PHR)

Linetsky David — President, Network Solutions
Jan 8, 2026
Sale
Shares
6,106
Price
$17.01
Total Value
$103.85K
Shares Held After
231,723
% of Holdings
2.6%
Jan 8, 2026
Purchase
Shares
1,500
Price
$1.60
Total Value
$2.40K
Shares Held After
12,233
% of Holdings
12.3%

Phreesia, Inc. (PHR)

Indig Chaim — Director
Jan 8, 2026
Sale
Shares
8,440
Price
$17.01
Total Value
$143.54K
Shares Held After
1,374,168
% of Holdings
0.6%

Innovative Eyewear, Inc. (LUCY)

Dabrowski Konrad — Chief AI & Growth Officer
Jan 8, 2026
Purchase
Shares
1,300
Price
$1.58
Total Value
$2.05K
Shares Held After
12,804
% of Holdings
10.2%

Phreesia, Inc. (PHR)

Hui Yvonne — Principal Accounting Officer
Jan 8, 2026
Sale
Shares
372
Price
$17.47
Total Value
$6.50K
Shares Held After
29,910
% of Holdings
1.2%

Phreesia, Inc. (PHR)

Hoffman Allison C — General Counsel & Secretary
Jan 8, 2026
Sale
Shares
6,585
Price
$17.01
Total Value
$111.99K
Shares Held After
174,762
% of Holdings
3.6%

Phreesia, Inc. (PHR)

Gandhi Balaji — Chief Financial Officer
Jan 8, 2026
Sale
Shares
8,009
Price
$17.01
Total Value
$136.21K
Shares Held After
156,231
% of Holdings
4.9%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 8, 2026
Sale
Shares
3,195
Price
$6.09
Total Value
$19.46K
Shares Held After
750,367
% of Holdings
0.4%
Jan 8, 2026
Sale
Shares
23,038
Price
$17.65
Total Value
$406.62K
Shares Held After
350,180
% of Holdings
6.2%
Jan 8, 2026
Sale
Shares
850
Price
$1.80
Total Value
$1.53K
Shares Held After
1,036,356
% of Holdings
0.1%

OMNICELL, INC. (OMCL)

Manley Corey J — EVP&CHIEF LEGAL/ADMIN OFFICER
Jan 8, 2026
Sale
Shares
6,106
Price
$49.90
Total Value
$304.69K
Shares Held After
91,674
% of Holdings
6.2%

Passage BIO, Inc. (PASG)

Chou William — Director
Jan 8, 2026
Sale
Shares
4,076
Price
$18.44
Total Value
$75.16K
Shares Held After
6,524
% of Holdings
38.5%
Jan 8, 2026
Sale
Shares
2,062
Price
$18.44
Total Value
$38.02K
Shares Held After
5,402
% of Holdings
27.6%
Jan 8, 2026
Purchase
Shares
30,000
Price
$16.30
Total Value
$489.00K
Shares Held After
346,155
% of Holdings
8.7%

MANNKIND CORP (MNKD)

Tross Stuart A — Chief People & Workpl Officer
Jan 8, 2026
Sale
Shares
47,006
Price
$6.33
Total Value
$297.55K
Shares Held After
985,007
% of Holdings
4.6%
Version: v26.3.33